Side by side
7.1/105 of 7 scored disclosures publishedBest for: patients who want unlimited visits and labs included without a plan-length commitment
$299/moper month, month-to-month
2.9/102 of 7 scored disclosures publishedBest for: readers who want to compare a published plan-length pricing ladder before committing
$119/moper month, but only on the 12-month plan paid up front at $1,428 total; the month-to-month rate is higher
At a glance
| Compared on | Apex MD | bmiMD |
|---|---|---|
| Pricing structure | Apex MDOne rate per drug, already the month-to-month price, holding across doses | bmiMDA published ladder keyed to plan length; within any term the rate holds across doses |
| Plan commitment | Apex MDNone — nothing is prepaid to reach the published figure | bmiMDThe lowest rung requires a twelve-month prepayment; monthly billing sits well above it |
| Cancellation terms | Apex MDNo plan-length penalty to plan around | bmiMDA non-refundable fee applies if you cancel after intake is approved |
| What the price covers | Apex MDUnlimited provider visits and Labcorp lab work are included in the monthly rate | bmiMDThe checkout charge is described as an authorization hold, released with no charge if a provider declines the patient |
| Formulation | Apex MDCompounded GLP-1 with NAD, B-12, and L-carnitine added, rather than a single-ingredient product | bmiMDCompounded semaglutide and tirzepatide, plus a newer lower-dose line on the same pricing structure |
| Format offered | Apex MDWeekly injection or a daily oral dose of each compound | bmiMDNo oral option published |
| Who is behind the brand | Apex MDNo operating entity published, and no accreditation seal displayed | bmiMDOperated by Medccm Inc., disclosed on the site, with a public Trustpilot profile |
| Compounding pharmacy | Apex MDNot named | bmiMDNot named |
| States served | Apex MDAll fifty states plus DC | bmiMDAll fifty states |
| Disclosure score | Apex MD7.1/10 | bmiMD2.9/10 |
What each one publishes
| Medication | Apex MD | bmiMD |
|---|---|---|
| Semaglutide (compounded) | Apex MD$299/moper month, month-to-monthall doses, injection · Verified August 2026 — | bmiMD$119/moper month, but only on the 12-month plan paid up front at $1,428 total; the month-to-month rate is higherflat rate, all doses · Verified September 2026 — |
| Tirzepatide (compounded) | Apex MD$399/moper month, month-to-monthall doses, injection · Verified August 2026 — | bmiMD$179/momonthly equivalent on the 12-month plan, with a displayed total of $2,148; the one-month plan is $249flat rate, all doses · Verified October 2026 — |
The commitment question, answered two ways
At Apex MD the published figure is what a patient pays with nothing prepaid. There is no ladder to climb and no annual prepayment to unlock a better number.
At bmiMD the published figures belong to plan terms, and the bottom rung is a prepaid year. bmiMD prints the rungs, which is more than most of this category does. A reader can do the arithmetic before handing over a card rather than meeting the structure at checkout.
Both approaches are honest. They suit different readers. A first-time patient who does not yet know whether a GLP-1 will suit them is being asked, at bmiMD, to choose between the best price and the ability to stop. Apex MD does not make them choose.
What leaving costs
bmiMD charges a non-refundable fee to cancel once intake has been approved. It is disclosed rather than hidden, and it is small next to the cost of a course of treatment. It also lands at exactly the point a patient would want to change their mind.
Set against a prepaid annual term, that makes bmiMD a provider to choose deliberately rather than to try. Apex MD has no equivalent term to plan around, because there is no plan length in the first place.
bmiMD does have a real counterweight. It describes the amount taken at checkout as an authorization hold, released without a charge if a provider declines the patient. That addresses the most common complaint in this category, which is being billed before anyone confirms eligibility.
The formulation difference, which is easy to miss in a table
Apex MD's compounded semaglutide and tirzepatide arrive with NAD, B-12, and L-carnitine in the same preparation. bmiMD's products are the compounded GLP-1 itself.
Apex MD publishes what is in its preparation. What those additions accomplish is not established here, and no clinical conclusion is invented to fill the gap. The point for a comparison is narrower: these are not the same preparation at two prices.
It also changes what to ask at intake. A multi-ingredient preparation is harder to reason about, which matters if you already take supplements or are trying to work out the source of a side effect.
What each one is willing to disclose
Neither names the pharmacy that compounds and dispenses the medication. That is the disclosure a reader would most want on a compounded product, and it is missing at both.
Past that, bmiMD publishes more. It names its operating entity, Medccm Inc., which a number of brands in this category never do, and it maintains a public third-party review profile rather than relying only on testimonials it selects. A public review profile is a place to read complaints, not a rating worth endorsing.
Apex MD publishes no operating entity and displays no third-party accreditation seal. On a preparation that differs from the standard compounded product, those two absences together are the weakest point in an otherwise clean offer.
Coverage, and what neither sells
Apex MD is licensed across all fifty states plus the District of Columbia. bmiMD advertises all fifty states. Availability is unlikely to decide this for most readers.
Neither publishes a brand-name option. Everything both sell in this category is compounded, prepared by a compounding pharmacy, and not an FDA-approved finished drug product. A reader who wants an approved medication is comparing the wrong pair.
So which one
It depends on which of these matters more to you. If you want to start without prepaying anything, keep the ability to stop, and use visits and labs that are already inside the rate, Apex MD is built for that.
If you are confident about a full course of treatment, bmiMD publishes more of what you would be signing. It prints every rung of the ladder and names the legal entity behind the brand.
Boards both of these appear on
Apex MD and bmiMD both qualify for 4 of the 6 boards on this site. Each board ranks a wider field than these two, so a position here is against everyone on it, not against each other.
- Semaglutide — Apex MD #64, bmiMD #20, of 334
- Tirzepatide — Apex MD #61, bmiMD #19, of 319
- Cheapest Overall — Apex MD #67, bmiMD #21, of 396
- Cash Pay vs Insurance — Apex MD #30, bmiMD #7, of 80
Who each one is better for
Apex MD
- First-time patients who want to start with nothing prepaid and stop without a cancellation penalty.
- Readers who will actually use their follow-up visits and lab draws, since the monthly rate absorbs both instead of invoicing them.
- Patients who want the choice between a weekly injection and a daily oral dose of the same compound.
bmiMD
- Readers who want the whole plan-length ladder published so they can run the arithmetic before committing to anything.
- Patients confident enough in a full course of treatment to prepay a year for the lowest rung.
- Readers who will not deal with a brand that hides its operating entity, and who want the reassurance that a declined intake releases the hold rather than charging the card.
Frequently asked questions
Which one costs less?
It depends entirely on how long you stay. bmiMD's lowest rung requires prepaying a full year, and its month-to-month rate sits well above that rung. Apex MD publishes one rate with nothing prepaid. A reader certain of a full course of treatment may do better on bmiMD's bottom rung; a reader who might stop in month three is comparing bmiMD's monthly rate, not its advertised one. Read the plan term printed beside every bmiMD figure before treating it as a price.
What happens if I want to cancel?
At bmiMD, a non-refundable fee applies once your intake has been approved. It is disclosed, and it is small relative to a course of treatment, but it lands at the moment most people would want to change their mind. Apex MD has no plan-length commitment, so there is no equivalent penalty to plan around. If keeping an exit open matters to you, that difference is larger than any gap between the two headline figures.
Are Apex MD and bmiMD selling the same medication?
Not quite. Apex MD's compounded semaglutide and tirzepatide carry NAD, B-12, and L-carnitine in the same preparation. bmiMD sells the compounded GLP-1 itself, plus a newer lower-dose line on the same pricing structure. Comparing the two monthly figures as though they bought the same thing is misleading. What is in Apex MD's preparation is stated because Apex MD states it; what the additions accomplish is not established, and nothing is invented to fill that gap.
Does either one name the pharmacy that compounds the medication?
No. Neither publishes the name of the pharmacy that prepares and dispenses the prescription. bmiMD does name its operating entity, Medccm Inc., which lets you look up the company you are dealing with, and it keeps a public third-party review profile. Apex MD publishes neither an operating entity nor an accreditation seal. On the pharmacy question specifically, both fall short.
Are visits and labs included?
At Apex MD, yes — provider visits with no cap on the number, and Labcorp lab work, are inside the monthly rate rather than billed separately. Those are the line items most likely to turn a low headline figure into an expensive year. bmiMD publishes its pricing ladder rather than a bundled-services list, so confirm during intake what is and is not covered before comparing the two figures directly.